Showing results (711-720 of 1,005) with videos related to

Sort By:
Pageof 101
Investigational New Drugs|March 30, 2013
A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumorsE Raymond, J Alexandre, S Faivre, et al.
Transboundary and Emerging Diseases|April 30, 2025
Analysing WAHIS Animal Health Immediate Notifications to Understand Global Reporting Trends and Measure Early Warning Capacities (2005-2021)Shu-Yu Lin, Daniel Beltran-Alcrudo, Lina Awada, et al.
European Journal of Neurology|January 30, 2004
A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutationsM Al Jumah, R Majumdar, S Al Rajeh, et al.
Acta Anaesthesiologica Scandinavica|March 24, 2022
High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection: A double-blinded randomized clinical trial substudyHussein Nasser Awada, Kristin Julia Steinthorsdottir, Nicolai A Schultz, et al.
Journal of Cellular Biochemistry|July 24, 2014
Autotaxin downregulates LPS-induced microglia activation and pro-inflammatory cytokines productionRana Awada, Jean Sébastien Saulnier-Blache, Sandra Grès, et al.
Plos One|August 4, 2025
Modelling the drivers of outbreak communication in online media news for improved event-based surveillanceSolene Rodde, Pachka Hammami, Asma Mesdour, et al.
ESMO Open|June 2, 2022
Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysisG Nader-Marta, D Martins-Branco, E Agostinetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basisE Tomiak, M J Piccart, J Kerger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancerErica L Mayer, Jean-Francois Baurain, Joseph Sparano, et al.
Breast Cancer Research and Treatment|April 5, 2020
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitorsMaria Alice Franzoi, Caroline Vandeputte, Daniel Eiger, et al.
Pageof 101